Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:LMNS

Lumenis (LMNS) Stock Price, News & Analysis

Lumenis logo

About Lumenis Stock (NASDAQ:LMNS)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies. It offers products to hospitals, outpatient clinics, ambulatory surgery centers, physicians' offices, private clinics and aesthetic chains. Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured.

Remove Ads
Receive LMNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Lumenis and its competitors with MarketBeat's FREE daily newsletter.

LMNS Stock News Headlines

McDonald's Corp MCD
See More Headlines

LMNS Stock Analysis - Frequently Asked Questions

Lumenis Ltd. (NASDAQ:LMNS) released its earnings results on Tuesday, May, 12th. The medical equipment provider reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.11 by $0.05. Lumenis's quarterly revenue was up 4.1% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Lumenis investors own include Momentus (MNTS), Nano-X Imaging (NNOX), Supernus Pharmaceuticals (SUPN), Aralez Pharmaceuticals (ARLZ), Omeros (OMER), Performant Financial (PFMT) and Sientra (SIEN).

Company Calendar

Last Earnings
5/12/2015
Today
4/01/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:LMNS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Top Nuclear Stocks To Buy Now Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:LMNS) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners